Skip to main content

. 2022 Apr 5;13:1936. doi: 10.1038/s41467-022-29700-y

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Ezra Y Rosen ^1,^#, Helen H Won ^2,^8,^#, Youyun Zheng ³, Emiliano Cocco ^4,⁵, Duygu Selcuklu ², Yixiao Gong ², Noah D Friedman ^4,⁶, Ino de Bruijn ², Onur Sumer ², Craig M Bielski ^4,^6,⁷, Casey Savin ², Caitlin Bourque ², Christina Falcon ¹, Nikeysha Clarke ¹, Xiaohong Jing ², Fanli Meng ², Catherine Zimel ², Sophie Shifman ³, Srushti Kittane ³, Fan Wu ³, Marc Ladanyi ³, Kevin Ebata ⁸, Jennifer Kherani ⁸, Barbara J Brandhuber ⁸, James Fagin ¹, Eric J Sherman ¹, Natasha Rekhtman ³, Michael F Berger ^2,^3,⁷, Maurizio Scaltriti ^4,⁹, David M Hyman ⁸, Barry S Taylor ^2,^4,^6,^7,^8,^✉,^#, Alexander Drilon ^1,^✉,^#

PMCID: PMC8983712 PMID: 35383193

Correction to: Nature Communications 10.1038/s41467-022-28848-x, published online 18 March 2022.

In this article the author name Srushti Kittane was incorrectly written as Srusthi Kittane. The original article has been corrected.

Contributor Information

Barry S. Taylor, Email: taylor.lab.msk@gmail.com

Alexander Drilon, Email: drilona@mskcc.org.

ACTIONS

RESOURCES